Evidence map›Paper›PMID 40852133›Full record

ArticleRoyal Society open science2025

Potential benefits of adaptive control strategies are outweighed by costs of infrequent, but dramatically larger disease outbreaks.

Samuel M Smith, Colleen T Webb, Stefan Sellman, Tom Lindström, Lindsay M Beck-Johnson

Abstract read
In one paragraph

Article in Royal Society open science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Samuel M SmithGraduate Degree Program in Ecology and Department of Biology, Colorado State University, Fort Collins, CO, USA.ORCID https://orcid.org/0000-0001-7400-2736
Colleen T WebbGraduate Degree Program in Ecology and Department of Biology, Colorado State University, Fort Collins, CO, USA.
Stefan SellmanDepartment of Physics, Chemistry and Biology, Linköping University, Linkoping, Sweden.
Tom LindströmDepartment of Physics, Chemistry and Biology, Linköping University, Linkoping, Sweden.
Lindsay M Beck-JohnsonGraduate Degree Program in Ecology and Department of Biology, Colorado State University, Fort Collins, CO, USA.ORCID https://orcid.org/0000-0001-7247-0309

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Understanding underlying transmission dynamics is necessary to effectively control an infectious disease outbreak. In the likely event that managers do not know where to target control resources because drivers of transmission are unknown, it may be desirable to tailor control strategies to a given outbreak by implementing control actions gradually in response to changes in the outbreak (adaptive) rather than all at once (fixed). Adaptive control strategies may also prevent over-reaction and thus causing unnecessary socioeconomic harm. However, it remains unclear whether the benefits of adaptive control strategies outweigh the potential of under-reacting and causing larger outbreaks. To weigh this trade-off, we used a validated national scale foot and mouth disease transmission model to compare how adaptive and fixed control strategies as well as various attributes of the control process affect outbreak size. We find that adaptive control strategies do not cost less for the vast majority of outbreaks, but infrequently result in much larger and more costly outbreaks owing to decision-making time and case reporting lags. This study emphasizes the cost of under-reacting to a disease outbreak and that minimizing decision-making time should be a key consideration when developing outbreak response guidelines.

Indexed as

adaptive controldecision makingemergency disease managementfoot and mouth diseaselivestock diseaseresponse delay

Identifiers

PMID40852133
PMCPMC12368609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.